Home › NDC Lookup › Ingredients › Supreh Bee Venom Arthritis Pain Relievin... › 83818-0016-01
SupreH Bee Venom Arthritis Pain Relieving Cream 1 g/100g; 1 g/100g; 1.25 g/100g Cream, 100 g — NDC 83818-0016-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

SupreH Bee Venom Arthritis Pain Relieving Cream 1 g/100g; 1 g/100g; 1.25 g/100g Cream, 100 g — NDC 83818-016-01 (Billing 83818-0016-01)

by Shenzhen Xinxin Yunhai Technology Co., Ltd. · 100 g in 1 BOTTLE

This is a package of 100 g of SupreH Bee Venom Arthritis Pain Relieving Cream 1 g/100g; 1 g/100g; 1.25 g/100g Cream from Shenzhen Xinxin Yunhai Technology Co., Ltd., marketed since Jun 2025 and currently FDA-listed. It is this product's only package size.

NDC 83818-0016-01
🏷️ FDA NDC (as labeled) 83818-016-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 83818-016-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83818 labeler · 016 product · 01 package
Package marketed since
Jun 26, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 8381801601 3
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83818-016-01
Product NDC 83818-016
11-digit billing NDC 83818001601
UNII HCK8PG4YA2, 76013O881M, B86IS274O0
Application # M017
SPL Set ID 3876cc44-7f3a-b084-e063-6294a90a6142
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-06-26
Route TOPICAL
Dosage form CREAM
Substance ARTEMISIA ARGYI WHOLE; APIS MELLIFERA VENOM; CARTHAMUS TINCTORIUS FLOWER BUD
Why two NDCs? The FDA registers this code as 83818-016-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83818-0016-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

SupreH Bee Venom Arthritis Pain Relieving Cream is a topical cream marketed as an OTC monograph product. It contains bee venom, mugwort (Artemisia argyi), and safflower flower bud as active ingredients. These botanical and animal-derived substances are commonly included in topical pain-relief products, where they are typically used to produce a warming or soothing sensation on the skin. The cream is applied directly to affected areas and is intended for use in managing minor joint and muscle discomfort associated with arthritis.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83818-0016-01 You're viewing this Main listing 100 g in 1 BOTTLE 2025-06-26 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
SupreH Bee Venom Arthritis Pain Relieving Cream 1 g/100g; 1 g/100g; 1.25 g/100gthis 83818-0016-01 Shenzhen 100 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 4PW41QCO2M
    Indian frankincense is a natural resin extracted from trees native to India. It is used in medicines as a binder and thickening agent to help hold ingredients together and improve texture.
  • UNII WS4CQ062KM
    A plant-derived spice from cinnamon bark, used as a flavoring agent to mask bitter tastes and add pleasant aroma to medicines.
  • UNII JC71GJ1F3L
    Myrrh is a natural resin obtained from a tree, traditionally used in medicines and perfumes. It may serve as a flavoring agent, fragrance, or mild preservative in formulations.
  • UNII L878N1L0AR
    A plant extract from the bark of the eucommia tree, used in some formulations as a thickening or binding agent to help hold the medicine together and control how it dissolves.
  • UNII C5529G5JPQ
    Ginger is a plant-derived ingredient used as a flavoring agent to add taste and aroma to medicines. It may also provide mild soothing properties to support product palatability.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCommiphora Myrrha Resin, Eucommia Ulmoides Bark, Chinese Cinnamon, Zingiber Officinale Root, Boswellia Serrata Resin

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerShenzhen Xinxin Yunhai Technology Co., Ltd.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code83818
First marketedJun 2025
Product typeHuman Otc Drug
Portfolio37 products on file

More NDCs from Shenzhen Xinxin Yunhai Technology Co., Ltd. labeler code 83818

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 19 words ▾

Use For the temporary relief minor pain associated with arthritis, simple backache, muscle strains, sprains, bruises and joint stiffness

⏱️ Dosage and Administration 30 words ▾

Directions Adult s & children 12 years and over: Apply to affected areas no more than 3-4 times daily. Wash hands after applying. Children under 12 yrs: Ask a doctor.

⚠️ Warnings 24 words ▾

Warnings For external use only. Do not use this product on irritated skin, or on open wounds. Perform skin test prior to initial use.

📦 Storage and Handling 12 words ▾

Other information Store at room temperature, away from heat and direct sunlight.

🧪 Active Ingredient 11 words ▾

Active Ingredient Artemisia Argyi, Carthamus Tinctorius Flower Bud, Apis mellifera venom

🧪 Inactive Ingredients 16 words ▾

Inactive ingredients Commiphora Myrrha Resin, Eucommia Ulmoides Bark, Chinese Cinnamon, Zingiber Officinale Root, Boswellia Serrata Resin

🎯 Purpose 16 words ▾

Purpose Artemisia Argyi 1%……Topical analgesic Carthamus Tinctorius Flower Bud 1.25%………Topical analgesic Apis Mellifera Venom 1%……Topical analgesic

📄 When Using This Product 15 words ▾

When Using this product Avoid contact with eyes or mucous membranes. Do not bandage tightly.

📄 Stop Use and Ask a Doctor If 19 words ▾

Stop use and ask a doctor if 1.Condition worsens 2.Pain persists more than 7 days 3.Rash or irritation develops

📄 Keep Out of Reach of Children 19 words ▾

Keep Out Of Reach Of Children If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 15 words ▾

Allergy Alert Contains bee-derived ingredients. Do not use if you are allergic to bee stings.

📄 Questions or Comments 7 words ▾

Questions or comments? Contact us at [email protected]

📄 Package Label / Principal Display Panel 4 words ▾

PRINCIPAL DISPLAY PANEL 1

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Shenzhen Xinxin Yunhai Technology Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Shenzhen Xinxin Yunhai Technology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 83818-0015-01 · Shenzhen 83818-0017-01 · Shenzhen →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.